mhurhangee/ep-ind-claims huggingface dataset:
A measurement and data communication device for use in or with an intraoral dental radiology system, the radiology system comprising: an x-ray data management unit having a first communication means for retrieving at least x-ray exposure data, and a processing means for processing at least the retrieved data; an intraoral x-ray generation unit having an x-ray source for exposing at least part of a patient jaw with x-rays; and an intraoral x-ray acquisition unit having a first x-ray sensor for acquiring x-ray image data of at least part of the patient jaw; said device characterized by comprising: a measurement unit for measuring features related to the x-rays used for exposing at least part of the patient, wherein the measurement unit is adapted to be arranged in use between the x-ray source and the patient; and a second communication means for transmitting the x-ray exposure data which includes the measured features to the x-ray data management unit. an x-ray data management unit having a first communication means for retrieving at least x-ray exposure data, and a processing means for processing at least the retrieved data; an intraoral x-ray generation unit having an x-ray source for exposing at least part of a patient jaw with x-rays; and an intraoral x-ray acquisition unit having a first x-ray sensor for acquiring x-ray image data of at least part of the patient jaw; said device characterized by comprising: a measurement unit for measuring features related to the x-rays used for exposing at least part of the patient, wherein the measurement unit is adapted to be arranged in use between the x-ray source and the patient; and a second communication means for transmitting the x-ray exposure data which includes the measured features to the x-ray data management unit. a measurement unit for measuring features related to the x-rays used for exposing at least part of the patient, wherein the measurement unit is adapted to be arranged in use between the x-ray source and the patient; and a second communication means for transmitting the x-ray exposure data which includes the measured features to the x-ray data management unit.
A temperature-sensing RFID device, comprising: an RFID chip including a temperature sensor; an antenna electrically coupled to the RFID chip and adapted to receive energy from an RF field and produce a signal, characterized by the antenna comprising first and second conductors (16, 18) positioned at opposite lateral sides of the RFID chip and electrically coupled to the RFID chip by a strap, and a conductive loop extending between the first and second conductors (16, 18), the conductive loop comprising a bridge spaced away from the RFID chip and the first and second conductors (16, 18), a first leg extending between the first conductor and the bridge and associated with a first end of the bridge, and a second leg extending between the second conductor and the bridge and associated with a second end of the bridge; wherein the conductive loop comprises an extension extending between the RFID chip and the bridge and associated with a midsection of the bridge, wherein a portion of the extension is in direct contact with the RFID chip and is configured to be in direct contact with an article to which the temperature-sensing RFID device is to be secured such that the portion serves as a thermally conductive or absorbent structure configured to enhance thermal coupling between the temperature sensor and said article. an RFID chip including a temperature sensor; an antenna electrically coupled to the RFID chip and adapted to receive energy from an RF field and produce a signal, characterized by the antenna comprising first and second conductors (16, 18) positioned at opposite lateral sides of the RFID chip and electrically coupled to the RFID chip by a strap, and a conductive loop extending between the first and second conductors (16, 18), the conductive loop comprising a bridge spaced away from the RFID chip and the first and second conductors (16, 18), a first leg extending between the first conductor and the bridge and associated with a first end of the bridge, and a second leg extending between the second conductor and the bridge and associated with a second end of the bridge; wherein the conductive loop comprises an extension extending between the RFID chip and the bridge and associated with a midsection of the bridge, wherein a portion of the extension is in direct contact with the RFID chip and is configured to be in direct contact with an article to which the temperature-sensing RFID device is to be secured such that the portion serves as a thermally conductive or absorbent structure configured to enhance thermal coupling between the temperature sensor and said article.
A magnifier assembly including a monitor with a screen for displaying images and a camera for viewing objects, the assembly comprising: a stand for supporting the assembly upon a surface, the stand including a body portion with first and second ends, a bridge extending between and interconnecting the first and second ends of the stand, the bridge formed into a U-shape trough; a flexible camera arm for connecting the camera to the stand, the flexible camera arm dimensioned to be received within the U-shape trough, the flexible camera arm having a proximal end connected to the first end of the stand via a hinge, the flexible camera arm also including a distal end that is connected to the camera, the hinge permitting the flexible camera arm to be selectively positioned either in front of the monitor or within the bridge, when the flexible camera arm is positioned within the bridge, the camera is adjacent the second end of the stand and the bridge and the flexible camera arm together form a handle by which the user may carry the assembly. a stand for supporting the assembly upon a surface, the stand including a body portion with first and second ends, a bridge extending between and interconnecting the first and second ends of the stand, the bridge formed into a U-shape trough; a flexible camera arm for connecting the camera to the stand, the flexible camera arm dimensioned to be received within the U-shape trough, the flexible camera arm having a proximal end connected to the first end of the stand via a hinge, the flexible camera arm also including a distal end that is connected to the camera, the hinge permitting the flexible camera arm to be selectively positioned either in front of the monitor or within the bridge, when the flexible camera arm is positioned within the bridge, the camera is adjacent the second end of the stand and the bridge and the flexible camera arm together form a handle by which the user may carry the assembly.
A method for indicating physical obstacles while displaying a virtual reality environment, the method comprising: at an electronic device with one or more processors, memory, and one or more cameras: displaying a virtual reality environment; determining a distance between the electronic device and a physical object; determining whether the distance between the electronic device and the physical object is within a first threshold distance; in accordance with a determination that the distance is within the first threshold distance, displaying a visual effect in the virtual reality environment; determining whether the distance between the electronic device and the physical object is within a second threshold distance, wherein the second threshold distance is smaller than first threshold distance; and in accordance with a determination that the distance is within the second threshold distance: replacing at least a first portion of the display of the virtual reality environment with a visual representation of at least part of a physical environment, the visual representation provided using the one or more cameras; and continuing displaying a second portion of the display of the virtual reality environment, wherein the second portion of the display of the virtual reality environment is different from the first portion of the display of the virtual reality environment. displaying a virtual reality environment; determining a distance between the electronic device and a physical object; determining whether the distance between the electronic device and the physical object is within a first threshold distance; in accordance with a determination that the distance is within the first threshold distance, displaying a visual effect in the virtual reality environment; determining whether the distance between the electronic device and the physical object is within a second threshold distance, wherein the second threshold distance is smaller than first threshold distance; and in accordance with a determination that the distance is within the second threshold distance: replacing at least a first portion of the display of the virtual reality environment with a visual representation of at least part of a physical environment, the visual representation provided using the one or more cameras; and continuing displaying a second portion of the display of the virtual reality environment, wherein the second portion of the display of the virtual reality environment is different from the first portion of the display of the virtual reality environment. replacing at least a first portion of the display of the virtual reality environment with a visual representation of at least part of a physical environment, the visual representation provided using the one or more cameras; and continuing displaying a second portion of the display of the virtual reality environment, wherein the second portion of the display of the virtual reality environment is different from the first portion of the display of the virtual reality environment.
An aircraft power system comprising: i) a hydraulic fluid reservoir, ii) a bi-directional hydraulic pump for pumping hydraulic fluid to and from the reservoir, and iii) an electric motor, wherein: the electric motor is connectable to a first driveable component of the aircraft such that the electric motor is arranged to drive the first driveable component of the aircraft; the hydraulic pump is connectable to the first driveable component of the aircraft such that the hydraulic pump is arranged to act as a hydraulic motor to drive the first driveable component, such that, in a first driveable mode of operation, the first driveable component is driven by both the electric motor and the hydraulic pump; the electric motor and hydraulic pump are connected to each other in parallel such that, in the first driveable mode of operation, both are arranged to supply power to the driveable component independently of the other; characterised in that: the electric motor is connectable to the hydraulic pump such that, during a replenishing mode of operation, the electric motor is arranged to drive the hydraulic pump to pump hydraulic fluid into the reservoir. i) a hydraulic fluid reservoir, ii) a bi-directional hydraulic pump for pumping hydraulic fluid to and from the reservoir, and iii) an electric motor, the electric motor is connectable to a first driveable component of the aircraft such that the electric motor is arranged to drive the first driveable component of the aircraft; the hydraulic pump is connectable to the first driveable component of the aircraft such that the hydraulic pump is arranged to act as a hydraulic motor to drive the first driveable component, such that, in a first driveable mode of operation, the first driveable component is driven by both the electric motor and the hydraulic pump; the electric motor and hydraulic pump are connected to each other in parallel such that, in the first driveable mode of operation, both are arranged to supply power to the driveable component independently of the other; characterised in that: the electric motor is connectable to the hydraulic pump such that, during a replenishing mode of operation, the electric motor is arranged to drive the hydraulic pump to pump hydraulic fluid into the reservoir.
A sulfided bulk metallic catalyst prepared by combining a Group VIII metal, a Group VIB metal, and an organic complexing agent that is an organic acid that contains a -COOH functional group and at least one additional functional group selected from carboxylic acid -COOH, hydroxmate acid -NOH-C=O, hydroxo -OH, keto -C=O, amine -NH2, amide: -CO-NH2, imine: -CNOH, epoxy: =COC=, or thiol: -SH, wherein the molar ratio of organic complexing agent to metal is greater than 3:1, to form a catalyst precursor composition, the catalyst precursor composition having a surface area of 16 m2/g or less based on Brunauer-Ernett-Teller method, and sulfiding the catalyst precursor composition to form the catalyst,wherein the catalyst precursor composition contains from 10 wt.% to 60 wt.% of an organic compound-based component formed from the organic complexing agent. combining a Group VIII metal, a Group VIB metal, and an organic complexing agent that is an organic acid that contains a -COOH functional group and at least one additional functional group selected from carboxylic acid -COOH, hydroxmate acid -NOH-C=O, hydroxo -OH, keto -C=O, amine -NH2, amide: -CO-NH2, imine: -CNOH, epoxy: =COC=, or thiol: -SH, wherein the molar ratio of organic complexing agent to metal is greater than 3:1, to form a catalyst precursor composition, the catalyst precursor composition having a surface area of 16 m2/g or less based on Brunauer-Ernett-Teller method, and sulfiding the catalyst precursor composition to form the catalyst,wherein the catalyst precursor composition contains from 10 wt.% to 60 wt.% of an organic compound-based component formed from the organic complexing agent.
A honeycomb filter, comprising: two or more honeycomb segments, each of which includes a plurality of porous partition portions each forming a cell, the cell being open at one end and closed at the other end and serving as a flow path of a fluid, and a trapping layer for trapping and removing solid components contained in the fluid, the trapping layer being disposed on each of the partition portions; and a bonding layer that is disposed between the two or more honeycomb segments and joins the outer surfaces of the two or more honeycomb segments together, wherein, in a cross section perpendicular to the flow path, the thickness of the trapping layer formed on each of outermost partitions of at least one honeycomb segment is 60% or less of the thickness of the trapping layer formed on each of partitions in an inner region, wherein the inner region is defined as a region inside the honeycomb segment having a width of half the width of the honeycomb segment. two or more honeycomb segments, each of which includes a plurality of porous partition portions each forming a cell, the cell being open at one end and closed at the other end and serving as a flow path of a fluid, and a trapping layer for trapping and removing solid components contained in the fluid, the trapping layer being disposed on each of the partition portions; and a bonding layer that is disposed between the two or more honeycomb segments and joins the outer surfaces of the two or more honeycomb segments together, wherein, in a cross section perpendicular to the flow path, the thickness of the trapping layer formed on each of outermost partitions of at least one honeycomb segment is 60% or less of the thickness of the trapping layer formed on each of partitions in an inner region, wherein the inner region is defined as a region inside the honeycomb segment having a width of half the width of the honeycomb segment.
Pre-filled syringe having a diameter greater than 3.00 mm, preferably comprised between 4.00 mm and 7,00 mm and being equipped with a needle having a length comprised preferably between 10 and 40 mm and containing a pharmaceutical composition comprising: 1) an aqueous solvent consisting of water and optionally of an organic solvent miscible with water, preferably an alcohol, more preferably ethanol, 2) lanreotide or one of its salts, preferably lanreotide acetate at a concentration ranging from 11 to 25% by weight of lanreotide, preferably from 18 to 25% by weight of lanreotide relative to the total weight of the composition, 3) optionally one or more amino acids, preferably arginine 4) optionally a monomeric excipient accepted by the pharmacopoeia characterized in that the said syringe is equipped with a standard needle having an outer diameter equal to or less than 1.00 mm and an inner diameter equal to or less than 0.80 mm, the diameter of these needles allowing to reduce the difficulty of implanting needles with an internal diameter of at least 1.00 mm. 1) an aqueous solvent consisting of water and optionally of an organic solvent miscible with water, preferably an alcohol, more preferably ethanol, 2) lanreotide or one of its salts, preferably lanreotide acetate at a concentration ranging from 11 to 25% by weight of lanreotide, preferably from 18 to 25% by weight of lanreotide relative to the total weight of the composition, 3) optionally one or more amino acids, preferably arginine 4) optionally a monomeric excipient accepted by the pharmacopoeia
A shallow water system comprising a floating weathervaning vessel with a topside hang-off structure, a subsea structure and at least one flexible transporting unit extending from the topside hang-off structure to the subsea structure, said weathervaning vessel has a bow with a lowermost bow midpoint, characterized in that the system is configured such that the weathervaning vessel is moored such that at still water it can weathervane around a weathervaning vertical centre line, such that the position of the lowermost bow midpoint follows an annular lowermost bow line, which defines a vertical tube shaped border to a lowermost bow midpoint exclusion zone (LE-zone), said subsea structure is arranged in said LE-zone, the subsea structure need not be arranged below the keel height of the weathervaning vessel and the uppermost point of the subsea structure has a distance from the sea surface and a distance of the LE-zone border sufficient to avoid collision with the weathervaning vessel under ordinary conditions, said weathervaning vertical centre line preferably is a nominal weathervaning vertical centre line.
A compound of Formula I: in which: Y is selected from N and CR 6; R 1 is -CH 2 CHMeNH OMe; R 2, R 3, R 5 and R 6 are independently selected from hydrogen, halo, cyano, C 1-4 alkyl, halo-substituted-C 1-4 alkyl, C 1-4 alkoxy and halo-substituted-C 1-4 alkoxy; with the proviso that when R 5 is fluoro, R 3 and R 6 are not both hydrogen; R 4 is selected from -R 9 and -NR 10 R 11; wherein R 9 is selected from C 1-6 alkyl, C 3-8 cycloalkyl, C 3-8 heterocycloalkyl, aryl and heteroaryl; wherein said alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl of R 9 is optionally substituted with 1 to 3 radicals independently selected from halo, cyano, C 1-4 alkyl, halo-substituted-C 1-4 alkyl, C 1-4 alkoxy and halo-substituted-C 1-4 alkoxy; and R 10 and R 11 are independently selected from hydrogen and R 9; R 7 is selected from C 1-4 alkyl, C 3-5 cycloalkyl and C 3-5 heterocycloalkyl; wherein said alkyl, cycloalkyl or heterocycloalkyl of R 7 is optionally substituted with 1 to 3 radicals independently selected from halo, cyano, hydroxyl, C 1-4 alkyl, halo-substituted-C 1-4 alkyl, C 1-4 alkoxy and halo-substituted-C 1-4 alkoxy; or R 7 is hydrogen; and the N-oxide derivatives, the tautomers, and the pharmaceutically acceptable salts and solvates (e.g. hydrates) of such compounds. Y is selected from N and CR 6; R 1 is -CH 2 CHMeNH OMe; R 2, R 3, R 5 and R 6 are independently selected from hydrogen, halo, cyano, C 1-4 alkyl, halo-substituted-C 1-4 alkyl, C 1-4 alkoxy and halo-substituted-C 1-4 alkoxy; with the proviso that when R 5 is fluoro, R 3 and R 6 are not both hydrogen; R 4 is selected from -R 9 and -NR 10 R 11; wherein R 9 is selected from C 1-6 alkyl, C 3-8 cycloalkyl, C 3-8 heterocycloalkyl, aryl and heteroaryl; wherein said alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl of R 9 is optionally substituted with 1 to 3 radicals independently selected from halo, cyano, C 1-4 alkyl, halo-substituted-C 1-4 alkyl, C 1-4 alkoxy and halo-substituted-C 1-4 alkoxy; and R 10 and R 11 are independently selected from hydrogen and R 9; R 7 is selected from C 1-4 alkyl, C 3-5 cycloalkyl and C 3-5 heterocycloalkyl; wherein said alkyl, cycloalkyl or heterocycloalkyl of R 7 is optionally substituted with 1 to 3 radicals independently selected from halo, cyano, hydroxyl, C 1-4 alkyl, halo-substituted-C 1-4 alkyl, C 1-4 alkoxy and halo-substituted-C 1-4 alkoxy; or R 7 is hydrogen; and the N-oxide derivatives, the tautomers, and the pharmaceutically acceptable salts and solvates (e.g. hydrates) of such compounds.
Process for producing polycrystalline silicon, which comprises introducing a reaction gas comprising hydrogen and silane and/or halosilane into a reactor, the reactor comprising at least one heated carrier body on which elemental silicon is deposited by means of pyrolysis to form the polycrystalline silicon, and where, in a continuous operation, offgas is taken off from the reactor and hydrogen recovered from this offgas is resupplied to the reactor as recycle gas, characterized in that the recycle gas has a nitrogen content of less than 1000 ppmv.
Actuation arrangement for a building closure, comprising a mechanical building closure drive and a latching means, which has at least one locking latch which in a latching position fixes a casement of the building closure in a closed position with respect to a frame and in a release position releases said casement to open the building closure, the latching means having at least one fastening means receiver for receiving a fastening means, which is for fastening the latching means on a frame element of the building closure, characterised in that a guide device of the mechanical building closure drive has a fastening opening, which is flush with the fastening means receiver, for receiving the fastening means, in such a way that the latching means and the guide device can be jointly fastened on the frame element using the fastening means.